Dr. Koh, Jong Sung is the Winner of 2015 Daewoong Achievement Award

  • October 04, 2015 10:58 PM
    Message # 3559942

    It is with our utmost pleasure to announce Dr. Koh, Jong Sung as the winner of 2015 Daewoong-KASBP Achievement Award. Dr. Koh will deliver the awardee lecture at the upcoming KASBP Fall Symposium. Please join us in congratulating him on the award and celebrating his great achievement in drug development at the symposium. Dr. Koh's biographical sketch as well as the abstract of his talk is shown below.

    ---------------

    Joyful journeys to create, add, and promote value as a new drug discoverer


    Jong Sung Koh, Ph.D., Chief Technology Officer, Genosco

    New drug discovery and development is like a marathon that requires endurance and commitment.  Success in making new medicine requires immense resources and a deeper understanding of rigorous R&D process.  It also takes persistence and sometimes, luck.  Ultimately, though, discovery of new medicine brings hope and relief to millions of patients.  In that sense, the process of drug discovery is a joyful journey if you enjoy the scientific process of making a new medicine.  However, there are also often many dead ends and setbacks.  To overcome the agonies in the dead ends and setbacks, drug discoverer needs high adversity quotient (AQ) to turn obstacles into opportunities.  

    Over 25 years, I have been involved in new drug discovery in the areas of anti-HIV, anti-diabetes, anti-cancers, and rheumatoid arthritis.  This talk presents my journey as a drug discoverer and immense satisfaction it has given me over the years.  The audacious journey from Deaduk Science town to Cambridge is also presented.


    2008 ~ present

    CTO, GENOSCO & President, KABIC

    2007 ~ 2008

    Head, Korea Research Institute of Chemical Technology (KRICT)

    (Anti-Cancer Research Center)

    2005 ~ 2007

    Managing Director, Vice President, LG Life Sciences, Ltd.

    2001 ~ 2005

    Vice president, Drug Discovery, LG Life Sciences, Ltd.

    (Anti-Diabetes)

    1991 ~ 2000

    Group Leader, LG Chem, Ltd.

    (Anti-Cancer & HTS)

    1995 ~ 1996

    Visiting Scholar, Department of Chemistry, UC Berkeley

    (Combinatorial Chemistry)

    1990 ~ 1991

    Senior Research Associate, The Scripps Research Institute

    (Catalytic Antibody & Phage Display)

    1981 ~ 1985

    Senior Research Scientist, Lucky Ltd.


    Last modified: October 04, 2015 11:00 PM | Anonymous member
Powered by Wild Apricot Membership Software